[1]
M. Nandy, “Clinical Trials to Combat Covid-19 (CTCC): Case Based Approach (CBA) of a NSE Listed Indian Pharmaceutical Company”, Adhyayan, vol. 10, no. 01, pp. 01-07, Jun. 2020.